Publications:4
- Home
- Profiles
Mount Sinai DoctorsJoji Tokita, MD
Nephrology
No Patient Experience Ratings
- About Me
- Education & Certifications
- Insurance
- Publications
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Education
MD, Rush Medical College at Rush University
Residency, Internal Medicine
Mount Sinai Beth Israel
Residency, Internal Medicine
Mount Sinai Beth Israel
Fellowship, Nephrology
Mount Sinai Beth Israel
Certifications
American Board of Internal Medicine
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Needle Migration to the Heart: An Unusual Association of Hemodialysis and Cardiovascular Morbidity. Rafael Honikman, Joanna Chikwe, Joji E.rik Tokita, Alexander J.C. Mittnacht. A & A case reports
- Effect of cholecalciferol supplementation on inflammation and cellular alloimmunity in hemodialysis patients: Data from a randomized controlled pilot trial. Lily Li, Marvin Lin, Maria Krassilnikova, Katya Ostrow, Amanda Bader, Brian Radbill, Jaime Uribarri, Joji Tokita, Staci Leisman, Vijay Lapsia, Randy A. Albrecht, Adolfo García-Sastre, Andrea D. Branch, Peter S. Heeger, Anita Mehrotra. PLoS ONE
- A prerotational, simulation-based workshop improves the safety of central venous catheter insertion: Results of a successful internal medicine house staff training program. Hiroshi Sekiguchi, Joji Erik Tokita, Taro Minami, Lewis Ari Eisen, Paul Henry Mayo, Mangala Narasimhan. Chest
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Tokita did not report having any of the following types of financial relationships with industry and other outside entities during 2023 and/or 2024: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Tokita did not report having any of the following types of financial relationships with industry and other outside entities during 2023 and/or 2024: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.